Next Article in Journal
Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways
Next Article in Special Issue
Allosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain
Previous Article in Journal
Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient
Previous Article in Special Issue
Structural Bioinformatics and Protein Docking Analysis of the Molecular Chaperone-Kinase Interactions: Towards Allosteric Inhibition of Protein Kinases by Targeting the Hsp90-Cdc37 Chaperone Machinery
Open AccessReview

Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?

1
Department of Psychology, Behavioral Neuroscience Area, Arizona State University, Tempe, AZ 85287, USA
2
Interdisciplinary Graduate Program in Neuroscience, Arizona State University, Tempe, AZ 85287, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2014, 7(1), 29-45; https://doi.org/10.3390/ph7010029
Received: 28 October 2013 / Revised: 13 December 2013 / Accepted: 24 December 2013 / Published: 30 December 2013
(This article belongs to the Special Issue Allosteric Modulators)
Positive allosteric modulators (PAMs) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are a diverse class of compounds that increase fast excitatory transmission in the brain. AMPA PAMs have been shown to facilitate long-term potentiation, strengthen communication between various cortical and subcortical regions, and some of these compounds increase the production and release of brain-derived neurotrophic factor (BDNF) in an activity-dependent manner. Through these mechanisms, AMPA PAMs have shown promise as broad spectrum pharmacotherapeutics in preclinical and clinical studies for various neurodegenerative and psychiatric disorders. In recent years, a small collection of preclinical animal studies has also shown that AMPA PAMs may have potential as pharmacotherapeutic adjuncts to extinction-based or cue-exposure therapies for the treatment of drug addiction. The present paper will review this preclinical literature, discuss novel data collected in our laboratory, and recommend future research directions for the possible development of AMPA PAMs as anti-addiction medications. View Full-Text
Keywords: AMPA PAMs; positive allosteric modulators; extinction; addiction AMPA PAMs; positive allosteric modulators; extinction; addiction
Show Figures

Figure 1

MDPI and ACS Style

Watterson, L.R.; Olive, M.F. Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction? Pharmaceuticals 2014, 7, 29-45.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop